Nia Health is a medical software developer focused on supporting individuals with chronic skin conditions, particularly atopic dermatitis. Its primary product, the Nia eczema app, delivers personalized, clinically validated information aimed at alleviating the burden and stigma associated with these conditions. The platform is designed to empower parents of children with eczema by providing them with effective treatment options and enhancing their confidence in managing the disease. By addressing inefficiencies in the healthcare system, Nia Health's solutions aim to lower costs while improving access to necessary medical resources for patients.
Operator of a microbiome research firm intended to transform microbiome research, diagnostics and therapeutics. The company delivers a high-throughput low-cost platform for dynamic and real-time analysis and quantification of the human gut microbiome, offering informed precision diagnostics and targeted therapies, enabling patients to improve their lives through novel approaches to lead a healthy life.
C-mo Medical Solutions specializes in developing monitoring devices aimed at providing a comprehensive assessment of cough patterns in patients. The company's portable and ergonomic wearables facilitate long monitoring periods and the detection of distinctive cough patterns. With fully automated analysis capabilities, these devices enable healthcare professionals to deliver accurate diagnoses and prescribe personalized treatment plans. By addressing key use-cases throughout the patient management lifecycle, C-mo Medical Solutions plays a significant role in enhancing cough-related healthcare.
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, specializing in bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Their diagnostic procedures utilize Next Generation Sequencing (NGS) technology, enabling intensive care clinicians to detect bacteria, fungi, viruses, and parasites present in patients' blood. Noscendo employs proprietary algorithms to evaluate the significance of each identified pathogen, thereby enhancing the accuracy and effectiveness of infection management in clinical settings.
Lindis Blood Care is focused on enhancing the outcomes of cancer surgeries through the development of a medical device that removes cancer cells from salvaged blood. This innovation facilitates the possibility of autologous blood transfusions, allowing cancer patients to receive their own blood collected during surgery. By enabling self-blood administration, Lindis Blood Care aims to improve the safety and effectiveness of blood transfusions for patients undergoing tumor removal, ultimately supporting better recovery and health outcomes.
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Veios is a modular clinic platform that digitizes and optimizes all clinic processes in a user-friendly way. The state-of-the-art software supports all staff in their daily work and additionally enables the development and use of innovations such as artificial intelligence, Big Data, telemedicine, patient applications and wearables to fundamentally improve patient care and research.
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a specific microRNA, which serves as a molecular master switch regulating pathological changes in the heart due to stress or injury. Cardior Pharmaceuticals is committed to discovering and clinically validating innovative therapies that address the underlying causes of cardiac dysfunction, ultimately striving to improve patients' health and quality of life.
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
Mediaire GmbH, founded in 2018 and based in Berlin, Germany, specializes in developing software solutions for medical imaging in the field of radiology. The company's flagship application, md.Brain, provides quantitative brain volumetry reports aimed at early detection of senile dementia and the automated measurement of medullary lesions associated with multiple sclerosis. By utilizing artificial intelligence, Mediaire enhances the workflow of radiologists through efficient image analysis, delivering precise examination results and diagnostic suggestions. This software is locally installed and is primarily targeted at radiologists and healthcare centers, improving the quality and speed of diagnostic and therapeutic procedures.
Heartbeat Medical develops a healthcare platform focused on tracking patient-reported outcomes. The platform serves as a comprehensive patient management tool suitable for healthcare facilities of all sizes. By emphasizing the importance of quality of life data, Heartbeat Medical enables healthcare providers to gain valuable insights through intelligent evaluations of diagnostics and treatment methods. This approach allows physicians and therapists to enhance their understanding of patient experiences and improve treatment strategies based on real-world evidence.
WISE Srl, established in 2011 and headquartered in Milan, Italy, specializes in the manufacture of implantable biomedical devices for biotechnology and biomedicine applications. The company employs advanced supersonic cluster beam implantation technology to integrate biocompatible, flexible, and stretchable conductive micro-electrodes into polymers, particularly elastomers. This innovative approach is primarily utilized in developing leads for neurostimulation, which are implanted in the spinal cord or brain to address neurodegenerative conditions such as chronic pain and Parkinson's disease. WISE aims to create a new generation of neuromodulation leads that are unbreakable, less invasive, and more cost-effective, enhancing treatment options for patients.
stimOS GmbH develops a drug delivery biochemical procedure that initiates bone formation, anti inflammatory activity, and healing process. The company also develops technologies and procedures that refine, functionalize, and activate implant materials. It also offers research and development of implant materials and implant surfaces. stimOS GmbH was founded in 2015 and is based in Constance, Germany.
Kumovis GmbH is a medical technology company based in Munich, Germany, that specializes in the manufacture of 3D-printing systems for medical applications. Founded in 2017, the company has developed the KUMOVIS R1, a 3D printing system that utilizes fused layer manufacturing for thermoplastic materials. Kumovis's systems are designed to produce a wide range of medical products, from prototyping to personalized human implants, and they emphasize clean room integration in their 3D printing processes. This focus on advanced printing technology allows Kumovis to cater to both industrial and medical sectors, enhancing the capabilities and customization of medical devices.
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, specializing in bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Their diagnostic procedures utilize Next Generation Sequencing (NGS) technology, enabling intensive care clinicians to detect bacteria, fungi, viruses, and parasites present in patients' blood. Noscendo employs proprietary algorithms to evaluate the significance of each identified pathogen, thereby enhancing the accuracy and effectiveness of infection management in clinical settings.
iATROS GmbH is a Munich-based company founded in 2019 that specializes in developing a mobile application and platform designed to connect cardiology patients with medical caregivers. The application offers a range of services including therapy and medication planning, progress tracking, ECG diagnosis, and maintenance of health data such as blood pressure and glucose levels. It also facilitates consultations with physicians, ensuring patients have 24/7 access to healthcare professionals. As the prevalence of cardiovascular diseases increases, iATROS aims to improve the lives of both chronic and acute cardiovascular patients while contributing to the reduction of healthcare costs. The company leverages smart health trackers and advanced AI analytics to enhance treatment outcomes, allowing patients to manage common heart conditions effectively.
Biograil, established in 2019 and led by CEO Karsten Lindhardt, specializes in developing a medical device that aims to enhance drug delivery systems. The device, produced through injection molding, is designed to fit within a standard-sized capsule and delivers active substances directly into the gastrointestinal wall. By utilizing the body's natural peristaltic forces, Biograil's technology eliminates the need for mechanical moving parts, allowing for a more efficient and pain-free administration of biologics. This innovative approach addresses the common challenges associated with traditional injection systems, offering a promising alternative for patients requiring medication.
Mecuris GmbH, founded in 2016 and based in Munich, Germany, specializes in the development and supply of custom orthopedic aids, including orthoses and prostheses. The company empowers orthopedic and prosthetic (O&P) professionals through its Mecuris Solution Platform, which integrates digital technology and 3D printing. This platform allows for the co-creation of individualized O&P products by utilizing patient data and scans to semi-automatically generate custom 3D designs. These designs can be printed locally, ensuring a tailored fit and reducing production times by up to 75%. Mecuris aims to enhance the lives of wearers by providing quick, personalized solutions that meet their specific needs.
Lindis Blood Care is focused on enhancing the outcomes of cancer surgeries through the development of a medical device that removes cancer cells from salvaged blood. This innovation facilitates the possibility of autologous blood transfusions, allowing cancer patients to receive their own blood collected during surgery. By enabling self-blood administration, Lindis Blood Care aims to improve the safety and effectiveness of blood transfusions for patients undergoing tumor removal, ultimately supporting better recovery and health outcomes.
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Draupnir Bio is focused on developing innovative cholesterol-lowering medications aimed at preventing blood clots in the heart with greater efficacy than existing treatments. The company utilizes a platform that explores the glycome to create novel therapeutics, employing advanced techniques in array technology, protein chemistry, and carbohydrate chemistry. This platform enables the synthesis, screening, and selection of potent heparan sulfate glycomimetic drug candidates, targeting cardiovascular, inflammatory, and infectious diseases. Additionally, Draupnir Bio's technology includes the development of protein degraders that can target extracellular disease proteins, potentially addressing a wide range of unmet therapeutic needs across various medical conditions. This approach promises more convenient and accessible treatment options compared to traditional injectable therapies.
Vacis B.V. is a tissue engineering company based in Geleen, the Netherlands, founded in 2016. The company specializes in developing in situ tissue-engineered blood vessels aimed at improving vascular access for patients undergoing hemodialysis. Vacis's innovative technology involves the use of a synthetic rod that is implanted under the skin, prompting the body to generate a tissue capsule that matures into a functional blood vessel. This approach allows for the creation of autologous graft vessels, which offer enhanced patency and a reduced risk of complications compared to traditional prosthetic grafts. By providing novel therapeutic solutions for vascular surgery, Vacis addresses significant challenges in the field, including the frequent failure of prosthetic vascular grafts, thereby potentially lowering healthcare costs and improving patient outcomes.
miRdetect GmbH develops and markets n-vitro diagnostics. Its product includes miRcontrol GCT, a test kit for the detection of testicular cancer. The company also engages in research and development of new tests to detect cancers. miRdetect GmbH was founded in 2016 and is headquartered in Bremen, Germany.
Mediaire GmbH, founded in 2018 and based in Berlin, Germany, specializes in developing software solutions for medical imaging in the field of radiology. The company's flagship application, md.Brain, provides quantitative brain volumetry reports aimed at early detection of senile dementia and the automated measurement of medullary lesions associated with multiple sclerosis. By utilizing artificial intelligence, Mediaire enhances the workflow of radiologists through efficient image analysis, delivering precise examination results and diagnostic suggestions. This software is locally installed and is primarily targeted at radiologists and healthcare centers, improving the quality and speed of diagnostic and therapeutic procedures.
Mecuris GmbH, founded in 2016 and based in Munich, Germany, specializes in the development and supply of custom orthopedic aids, including orthoses and prostheses. The company empowers orthopedic and prosthetic (O&P) professionals through its Mecuris Solution Platform, which integrates digital technology and 3D printing. This platform allows for the co-creation of individualized O&P products by utilizing patient data and scans to semi-automatically generate custom 3D designs. These designs can be printed locally, ensuring a tailored fit and reducing production times by up to 75%. Mecuris aims to enhance the lives of wearers by providing quick, personalized solutions that meet their specific needs.
Kumovis GmbH is a medical technology company based in Munich, Germany, that specializes in the manufacture of 3D-printing systems for medical applications. Founded in 2017, the company has developed the KUMOVIS R1, a 3D printing system that utilizes fused layer manufacturing for thermoplastic materials. Kumovis's systems are designed to produce a wide range of medical products, from prototyping to personalized human implants, and they emphasize clean room integration in their 3D printing processes. This focus on advanced printing technology allows Kumovis to cater to both industrial and medical sectors, enhancing the capabilities and customization of medical devices.
advanceCOR GmbH is a drug development company based in Munich, Germany, specializing in therapeutics and diagnostics for heart and vascular diseases. Founded in 2000, the company focuses on creating personalized treatments and has developed several innovative products. Notable among these is Revacept, a human Fc fusion protein that inhibits the local activation of platelets at vascular injury sites. Additionally, advanceCOR offers COR-2, a recombinant protein that reduces foam cell generation and cholesterol uptake, and COR-3, which targets atherosclerotic plaques while binding to progenitor cells to promote plaque healing. The company’s product pipeline also includes therapies for acute arterial thrombosis, myocardial infarction, stroke, and transient ischemic attack, emphasizing its commitment to addressing serious cardiovascular conditions.
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Heartbeat Medical develops a healthcare platform focused on tracking patient-reported outcomes. The platform serves as a comprehensive patient management tool suitable for healthcare facilities of all sizes. By emphasizing the importance of quality of life data, Heartbeat Medical enables healthcare providers to gain valuable insights through intelligent evaluations of diagnostics and treatment methods. This approach allows physicians and therapists to enhance their understanding of patient experiences and improve treatment strategies based on real-world evidence.
RIMASYS is dedicated to advancing surgical education and medical technology research and development. The company focuses on creating realistic fractures in human specimens through a unique algorithm and device, which supports practical skill training for surgeons. By integrating digital learning, virtual reality, and 3D printing, RIMASYS aims to improve patient outcomes and enhance the quality of life for individuals requiring advanced therapies and operations. Their innovative approach facilitates collaboration among medical science, academia, and industry, fostering the development of better implants and surgical techniques.
stimOS GmbH develops a drug delivery biochemical procedure that initiates bone formation, anti inflammatory activity, and healing process. The company also develops technologies and procedures that refine, functionalize, and activate implant materials. It also offers research and development of implant materials and implant surfaces. stimOS GmbH was founded in 2015 and is based in Constance, Germany.
Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, established in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is a leading cause of mortality in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a specific microRNA, which serves as a molecular master switch regulating pathological changes in the heart due to stress or injury. Cardior Pharmaceuticals is committed to discovering and clinically validating innovative therapies that address the underlying causes of cardiac dysfunction, ultimately striving to improve patients' health and quality of life.
KSK Diagnostics GmbH, established in 2014 and based in Hamburg, Germany, specializes in the development of molecular point-of-care diagnostic assays aimed at diagnosing infectious diseases and cancer. The company utilizes isothermal amplification technology to create rapid tests that enable healthcare professionals to make timely diagnoses, often within 30 minutes, thereby facilitating prompt treatment decisions. In addition to its diagnostic assays, KSK Diagnostics offers customizable services, including the development of nucleic acid-based tests using real-time PCR or RT-PCR, as well as verification and validation studies and product enhancement services for other organizations in the healthcare sector. As a pioneer in this field, KSK Diagnostics is dedicated to improving patient-oriented diagnostics through innovative technologies.
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Mecuris GmbH, founded in 2016 and based in Munich, Germany, specializes in the development and supply of custom orthopedic aids, including orthoses and prostheses. The company empowers orthopedic and prosthetic (O&P) professionals through its Mecuris Solution Platform, which integrates digital technology and 3D printing. This platform allows for the co-creation of individualized O&P products by utilizing patient data and scans to semi-automatically generate custom 3D designs. These designs can be printed locally, ensuring a tailored fit and reducing production times by up to 75%. Mecuris aims to enhance the lives of wearers by providing quick, personalized solutions that meet their specific needs.
Immunic Therapeutics is a clinical-stage biopharmaceutical company focused on developing selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Its primary product, IMU-838, is a selective immune modulator currently in Phase 2 clinical trials for ulcerative colitis, relapsing-remitting multiple sclerosis, and Crohn's disease. Additionally, the company is advancing IMU-935, an inverse agonist targeting RORgt, and IMU-856, which aims to restore intestinal barrier function in patients with conditions such as inflammatory bowel disease and irritable bowel syndrome. Immunic Therapeutics is headquartered in New York, New York, and seeks to provide effective treatment options for a range of chronic inflammatory conditions through its innovative drug development initiatives.
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Heartbeat Medical develops a healthcare platform focused on tracking patient-reported outcomes. The platform serves as a comprehensive patient management tool suitable for healthcare facilities of all sizes. By emphasizing the importance of quality of life data, Heartbeat Medical enables healthcare providers to gain valuable insights through intelligent evaluations of diagnostics and treatment methods. This approach allows physicians and therapists to enhance their understanding of patient experiences and improve treatment strategies based on real-world evidence.
LifeTime has been developed by connected-health.eu GmbH since 2014 and has since grown into one of the leading and most secure solutions for digital delivery and decentralized management of medical data. LifeTime helps people better understand their health and treatment histories, as well as make their work more efficient, accurate and targeted for doctors and healthcare workers. LifeTime was taken over by LifeTime GmbH on 1 August 2019 and will be further developed from now on under a new roof.
Bomedus is a medical device company that aims to make people with pain more mobile again. The Germany-based company was founded in 2011.
Immunservice GmbH is engaged in the development and commercialization of biomimetic treatments aimed at cancer and infectious diseases. The company specializes in creating therapies based on immune hormones, particularly focusing on interleukin-2. Its flagship product, Pulmoleukin, is designed to prevent suffocation in patients with lung tumors by leveraging natural biomimetic approaches. Immunservice also addresses various orphan disease indications and offers services related to patent applications, biomimetic therapies, and clinical development. Founded in 2004 and based in Hamburg, Germany, the company emphasizes research on immune hormone interleukin-2 and provides insights for the advancement of diagnostic and pharmaceutical applications.
Preventicus GmbH develops solutions that record and analyze patients’ vital parameters for preclinical screening for risks and detection of lifestyle-related illnesses using smartphone applications. It serves private end users, corporate customers in the occupational health management sector, and OEM customers. The company was founded in 2014 and is headquartered in Jena, Germany.
Medineering is a medical technology company, which specializes in the development, patenting, and selling of innovative, robotic systems for the minimally invasive head surgery. The product portfolio consists of a modular set of surgical manipulators, which allow clinics and surgeons to choose the degree of automation and functionality, depending on the specific surgical requirements and financial constraints. It manufactures and markets an application-specific and convenient robotic portfolio. It consists of the Intelligent positioning arm and compact application-specific robots helping surgeons in complex anatomical regions. The company's mission is to identify potentials in minimally invasive surgery, which can be unlocked with the aid of robotics. Medineering was founded on 2014 and is headquartered in Munich, Germany.
Predemtec GmbH develops diagnostic tests to determine risk factors for dementia and other illnesses. It offers Predemtec DX, a serum-based immunoassay for use in the detection and risk diagnosis of senile dementia in Alzheimer patients and mild cognitive impairment patients. The company was founded in 2011 and is based in Hennigsdorf, Germany.
microDimensions GmbH, based in Munich, Germany, specializes in developing software solutions for the processing, analysis, and visualization of microscopic image data, particularly in the field of digital pathology. Founded in 2011, the company offers products such as Voloom, an automated software for 3D reconstruction and analysis of histology specimens, and Zoom, a viewer for rapid visualization of whole slide images. Their software aids researchers in pharmaceutical, biotechnology, and pathology sectors with various histological applications, including cell counting and tumor border computation. microDimensions also provides reconstruction and analysis services, ensuring that their solutions can be seamlessly integrated into existing workflows. The company's commitment to creating efficient algorithms and high-quality standards enhances the speed and accuracy of histological assessments for pathologists.
Coramaze Technologies GmbH is a medical device company focused on developing minimally invasive solutions for heart diseases. The company is known for its Mitramaze valve repair system, a catheter-based device designed to be implanted directly into the beating heart. This innovative system specifically targets inoperable and asymptomatic patients suffering from functional mitral regurgitation, a condition often resulting from heart enlargement due to heart attacks or heart failure. Founded in 2013, Coramaze Technologies is headquartered in Essen, Germany, and aims to offer a less invasive treatment option for patients who would otherwise have limited therapeutic alternatives.
dentaZOOM GmbH, founded in 2012 and based in Berlin, Germany, specializes in the development and sale of dental microscopes. The company’s microscopes are designed to enhance dental surgery by providing a compact, lightweight, and monocular solution that includes an integrated LED lighting system. This design allows dental professionals to utilize the microscopes seamlessly during patient treatments, improving visibility and precision in surgical procedures.
Photonics Healthcare is a medical device company specializing in the development and commercialization of clinical monitors for measuring cellular oxygen levels. Founded in 2009 and based in Garching, Germany, the company offers its flagship product, the COMET Monitor, which non-invasively assesses cellular oxygen metabolism, including both oxygen availability and consumption. This technology is crucial for healthcare providers, enabling them to monitor patients' tissue oxygen levels in real time, particularly in situations where oxygen supply is compromised or cellular metabolism is affected. Additionally, Photonics Healthcare engages in contract research programs to further advance its offerings in the medical monitoring field.
Middle Peak Medical is a privately held medical device company dedicated to developing innovative solutions for mitral valve disease. The company focuses on creating a proprietary device designed to address unmet needs in treating mitral valve regurgitation. This novel technology aims to restore mitral valve competence in both functional and degenerative conditions by providing a new posterior surface for the anterior leaflet to seal properly. The device is applicable in both percutaneous catheter-based interventions and minimally invasive or open-heart cardiac surgeries, positioning Middle Peak Medical as a key player in advancing treatment options for patients with mitral valve disorders.
Dolosys GmbH is a medical technology company based in Berlin, Germany, that specializes in developing and manufacturing devices for the objective measurement and management of pain. The company's innovative equipment aims to enhance pain therapy for sedated intensive care patients and those suffering from chronic pain. By providing healthcare organizations with effective tools for pain monitoring and stimulation, Dolosys enables improved pain management alternatives, ultimately contributing to better patient care and outcomes.
WISE Srl, established in 2011 and headquartered in Milan, Italy, specializes in the manufacture of implantable biomedical devices for biotechnology and biomedicine applications. The company employs advanced supersonic cluster beam implantation technology to integrate biocompatible, flexible, and stretchable conductive micro-electrodes into polymers, particularly elastomers. This innovative approach is primarily utilized in developing leads for neurostimulation, which are implanted in the spinal cord or brain to address neurodegenerative conditions such as chronic pain and Parkinson's disease. WISE aims to create a new generation of neuromodulation leads that are unbreakable, less invasive, and more cost-effective, enhancing treatment options for patients.
CardioSecur, developed by Personal MedSystems GmbH, is a mobile ECG system designed for smartphone use that enables users to monitor heart rate and rhythm, as well as detect circulation disturbances such as infarctions. Founded in 2008 and based in Frankfurt am Main, Germany, the company focuses on creating innovative and user-friendly health monitoring solutions. CardioSecur specializes in advanced 12-lead ECG technology that utilizes a reduced number of electrodes, ensuring both sophistication and ease of use. The company's goal is to provide professional-grade ECG systems that can be integrated into personalized applications, making cardiac monitoring accessible to individuals.
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
ADVANOVA GmbH develops VMobil software that allows medical professionals to access a patient’s complete electronic record on a mobile device. The company was founded in 2012 and is based in Erlangen, Germany.
Drug Response Dx is based in Hennigsdorf, Germany and was founded in February 2012 by Dr. Zoltán Konthur, Dr. Jörg-M. Hollidt, Dr. Karl Skriner and Dr. Joachim Rautter. The biomarker set is prevalidated; the biochemicals and test samples are present. The proof of concept in serums from RA patients is established.
Topsfield Medical GmbH develops medical devices for replacement that extends implant life. The company develops devices that address the underlying problem of premature implant loosening by improving the prosthesis fixation method. Topsfield Medical GmbH was founded in 2012 and is based in Berlin, Germany.
t-cell Europe is a medical company that develops T-cell-based therapies based on IP-protected platform technology.
GME German Medical Engineering GmbH is a German company specializing in the development and marketing of advanced laser and light systems for dermatological applications. Founded in 2011 and based in Erlangen, the company offers products designed for permanent hair removal, skin tightening, and the treatment of various skin conditions, including psoriasis and vitiligo. One of their notable products, the Linscan 808, is a diode laser that allows for effective hair removal without the need for anesthetics or gels. GME's systems are user-friendly, featuring Plug & Play installation, intelligent software for ease of use, and WiFi capabilities for effortless updates. The compact design of their equipment also facilitates transport. All products adhere to stringent German medical device standards and are fully developed and manufactured in Germany. GME markets its products globally through partner companies, leveraging extensive expertise in the industry.
Humedics GmbH, founded in 2009 and based in Berlin, Germany, specializes in the development of a breath analysis device designed to assess liver function in patients suffering from liver failure. The company's key product, the LiMAx test, is a diagnostic system that includes a medical device, breath masks, and a diagnostic drug, enabling clinicians to quantitatively evaluate individual liver function. This technology supports various applications, such as assessing liver function before and after transplantation, planning liver surgeries, and evaluating conditions like liver cirrhosis. By providing rapid and precise measurements at the bedside, LiMAx facilitates informed decision-making for tailored medical treatments, thereby enhancing patient outcomes. The company has successfully used its technology with thousands of patients and is focused on expanding its global operations.
Microstim GmbH develops a tissue and function maintaining implantable myostimulator designed to assist the heart. Particular strengths of Microstim GmbH are the microcontroller acquisition and processing of data, control of cardiac and muscle stimulator impulses, and wireless “in-bodyâ€-communication. At the national business plan contest “Science4Life†in 2008, Microstim GmbH was one of ten winners in the concept phase category.
GILUPI GmbH, a Potsdam, Germany-based company that develops and produces medical devices for the in vivo isolation of rare cells out of the circulating blood.
Curefab is a developer of medical technologies focused on the assessment of diagnostic image data. The company's innovations enhance diagnostic certainty and facilitate the early detection of cardiovascular and oncological diseases. Curefab's technologies are utilized in various applications, including stroke prevention, early diagnosis of vascular diseases, and the monitoring of cancer therapies. Additionally, the company offers computed sonography systems that enable the comparison and analysis of ultrasound image data, providing physicians with essential diagnostic parameters for improved patient outcomes.
Delphi Optics GmbH is a Germany-based company that develops and distributes automatic, optical classification systems for medical applications. It was founded in 2009 and is headquartered in Lübeck, Schleswig-Holstein.
Humedics GmbH, founded in 2009 and based in Berlin, Germany, specializes in the development of a breath analysis device designed to assess liver function in patients suffering from liver failure. The company's key product, the LiMAx test, is a diagnostic system that includes a medical device, breath masks, and a diagnostic drug, enabling clinicians to quantitatively evaluate individual liver function. This technology supports various applications, such as assessing liver function before and after transplantation, planning liver surgeries, and evaluating conditions like liver cirrhosis. By providing rapid and precise measurements at the bedside, LiMAx facilitates informed decision-making for tailored medical treatments, thereby enhancing patient outcomes. The company has successfully used its technology with thousands of patients and is focused on expanding its global operations.
SurgicEye GmbH, founded in 2008 and based in Munich, Germany, specializes in developing intra-operative imaging and instrument navigation solutions for surgical procedures. The company offers products such as declipse SPECT open surgery, which utilizes handheld 3-D freehand SPECT imaging technology for navigated radio-guided surgery, and declipse SPECT Laparascopy, an intraoperative 3D imaging system designed for invasive sentinel lymph node biopsy. Additionally, SurgicEye provides the declipse SPECT imaging probe, a compact mobile SPECT imaging solution with high resolution. Beyond its product offerings, SurgicEye also offers consulting services in medical device development, including requirement engineering, software specification, software development, and testing, as well as support for the design and execution of clinical studies.
Amedrix GmbH specializes in the development of medical products aimed at regenerating soft tissue defects, particularly skin. Founded in 2009 and headquartered in Esslingen, Germany, the company focuses on native collagen solutions that serve as three-dimensional cell carrier materials. These innovative matrices facilitate the migration, proliferation, and regeneration of the body’s own cells without the need for a prior biopsy. Amedrix offers a diverse range of products, including collagen solutions, gels, membranes, sponges, and fleeces, which can be customized in various forms, sizes, and thicknesses to address a wide array of treatment needs.
Hematris Wound Care GmbH specializes in the development, manufacture, and marketing of hemostasis products aimed at enhancing patient outcomes. The company focuses on producing absorbent dressings that contain specific substances designed to stop severe arterial or venous bleeding promptly. These innovative products facilitate earlier mobilization of patients by effectively managing external wounds and preventing secondary bleeding. Hematris is dedicated to improving wound care solutions through its advanced offerings in the hemostasis field.
AVIDAL Vascular GmbH, based in Berlin, Germany, specializes in developing medical devices for the treatment of cardiovascular, peripheral vascular, and neurovascular diseases. Founded in 2009 by Torsten Heilmann, the company offers a variety of products, including drug-eluting balloons, specialty catheters, embolic protection stents, covered stents, biodegradable stents, and implantable left and right ventricular assist devices. In addition to its product offerings, AVIDAL provides a comprehensive platform for medical device manufacturers seeking to enter the Central European markets, offering services such as regulatory affairs, clinical study support, marketing, business development, and logistics. The company aims to ensure doctors have access to a diverse range of affordable medical devices, thereby enhancing patient care in various vascular domains.
Microstim GmbH develops a tissue and function maintaining implantable myostimulator designed to assist the heart. Particular strengths of Microstim GmbH are the microcontroller acquisition and processing of data, control of cardiac and muscle stimulator impulses, and wireless “in-bodyâ€-communication. At the national business plan contest “Science4Life†in 2008, Microstim GmbH was one of ten winners in the concept phase category.
SurgicEye GmbH, founded in 2008 and based in Munich, Germany, specializes in developing intra-operative imaging and instrument navigation solutions for surgical procedures. The company offers products such as declipse SPECT open surgery, which utilizes handheld 3-D freehand SPECT imaging technology for navigated radio-guided surgery, and declipse SPECT Laparascopy, an intraoperative 3D imaging system designed for invasive sentinel lymph node biopsy. Additionally, SurgicEye provides the declipse SPECT imaging probe, a compact mobile SPECT imaging solution with high resolution. Beyond its product offerings, SurgicEye also offers consulting services in medical device development, including requirement engineering, software specification, software development, and testing, as well as support for the design and execution of clinical studies.
ILIAS-medical GmbH
Seed Round in 2008
Die ILIAS-medical GmbH entwickelt die kleinste mobile, künstliche Lunge der Welt
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
awenydd diagnostics GmbH
Venture Round in 2008
awenydd diagnostics GmbH is a Germany-based company that analyzes patients and interactions they have with other drugs.
UroTec GmbH is a pharmaceutical company, founded in Germany in 2005. The spin-off from Dresden University of Technology develops and distributes implants from autologous cells for reconstruction of the lower urinary tract (tissue engineering).
Immunservice GmbH is engaged in the development and commercialization of biomimetic treatments aimed at cancer and infectious diseases. The company specializes in creating therapies based on immune hormones, particularly focusing on interleukin-2. Its flagship product, Pulmoleukin, is designed to prevent suffocation in patients with lung tumors by leveraging natural biomimetic approaches. Immunservice also addresses various orphan disease indications and offers services related to patent applications, biomimetic therapies, and clinical development. Founded in 2004 and based in Hamburg, Germany, the company emphasizes research on immune hormone interleukin-2 and provides insights for the advancement of diagnostic and pharmaceutical applications.
Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.
MEDOVENT GmbH was founded in summer 2006 by Dr. Thomas Freier and Dr. Rivelino Montenegro. Both have a long-term expertise in the field of biomaterial research and medical device development.
awenydd diagnostics GmbH
Seed Round in 2006
awenydd diagnostics GmbH is a Germany-based company that analyzes patients and interactions they have with other drugs.